Skip to main content
Industry News
Gilead resumes distribution control for remdesivir

The FDA announced that Gilead Sciences will now resume distribution control of its drug Veklury, or remdesivir, as a treatment for patients with COVID-19 infections. The FDA took over distribution of the drug in May following its authorization for emergency use of the drug at the height of the pandemic.

Full Story: